gener
ippexpand
cellsperipher
blood
mononuclear
cell
pbmc
isol
buffycoat
prepar
blood
healthi
donor
hong
kong
red
cross
ficollpaqu
pharmacia
gradient
centrifug
describ
elsewher
research
protocol
approv
institut
review
board
univers
hong
konghospit
author
hong
kong
west
cluster
pbmc
cultur
roswel
park
memori
institut
rpmi
medium
supplement
fetal
bovin
serum
ipp
sigma
ad
day
final
concentr
recombin
human
interleukin
invitrogen
ad
everi
day
begin
day
final
concentr
iuml
cultur
day
cell
purifi
neg
select
cell
isol
kit
miltenyi
biotec
accord
manufactur
instruct
cultur
mdmshuman
mdm
gener
mononuclear
cell
describ
elsewher
briefli
adher
monocyt
seed
flatbottom
plate
cellswel
plate
cellswel
refe
rpmi
supplement
autolog
serum
allow
differenti
macrophag
day
puriti
monocyt
determin
flow
cytometri
monoclon
antibodi
consist
viru
prepar
titrat
infectionhuman
flua
ahong
avian
flua
aquailhong
ahong
virus
use
virus
cultur
madindarbi
canin
kidney
cell
american
type
cultur
collect
describ
elsewher
viru
titer
determin
daili
observ
cytopath
effect
median
tissu
cultur
infect
dose
calcul
accord
reedmuench
formula
differenti
mdm
day
infect
flua
virus
multipl
infect
moi
h
viral
adsorpt
cell
wash
phosphatebuff
salin
remov
unadsorb
viru
cytotox
cell
effector
cocultur
mdm
target
differ
effectortotarget
e
ratio
h
afterward
nonadher
cell
harvest
directli
adher
cell
detach
acid
adher
nonadher
cell
stain
identifi
cell
ethidium
homodim
identifi
dead
cell
cytotox
cell
virusinfect
mdm
assess
flow
cytometri
percentag
cell
popul
transwel
cultur
cell
flua
mdmsto
evalu
cellcel
contact
requir
cell
cytotox
transwel
system
use
well
pore
size
millipor
mdm
target
bottom
well
infect
viru
moi
cell
effector
ad
directli
bottom
well
transwel
insert
e
ratio
insert
amount
virusinfect
mdm
ad
activ
cell
h
mdm
bottom
well
harvest
analyz
cell
death
describ
block
cell
effector
cocultur
mdm
target
e
ratio
h
neutral
antibodi
bd
bioscienc
antifasl
r
system
antitrail
r
system
respect
isotyp
control
ad
cocultur
block
fasl
trailmedi
pathway
respect
block
perforin
granzym
b
perforin
inhibitor
concanamycin
cma
sigma
granzym
b
inactiv
r
system
use
describ
elsewher
cytotox
analyz
flow
cytometri
describ
calcul
percentag
inhibit
rel
control
flow
cytometrycel
stain
surfac
marker
follow
antibodi
cell
receptor
tcr
antitrail
bd
bioscienc
antifasl
invitrogen
intracellular
stain
cell
fix
permeabil
stain
antiperforin
pfp
b
grb
antibodi
bd
bioscienc
respect
isotyp
control
sampl
acquir
use
bd
facsaria
cell
sorter
bd
bioscienc
analyz
mean
flowjo
softwar
version
tree
star
quantif
flua
viral
copi
reversetranscript
polymeras
chain
reactionmdm
infect
viru
moi
one
hour
later
unadsorb
viru
wash
away
care
mdm
cultur
alon
cell
h
cell
supernat
harvest
total
rna
extract
mean
trizol
ls
reagent
invitrogen
accord
manufactur
instruct
complementari
dna
synthes
oligo
dt
primer
superscript
ii
revers
transcriptas
invitrogen
viral
matrix
gene
copi
quantifi
basi
sybr
green
fluoresc
signal
polymeras
chain
reaction
forward
primer
revers
primer
mean
abi
prism
sequenc
detect
system
appli
biosystem
result
express
number
target
gene
copi
per
mdm
statist
analysisdata
express
mean
standard
error
mean
statist
signific
determin
student
test
nonparametr
test
use
graphpad
prism
softwar
version
differ
consid
signific
p
select
activ
expans
cell
ippconsist
previou
find
found
ipp
could
select
expand
cell
freshli
isol
pbmc
contain
cell
randomli
select
healthi
adult
donor
day
vitro
cultur
presenc
ipp
cell
expand
rang
percentag
cell
within
pbmc
increas
alon
increas
absolut
number
cell
puriti
cell
magnet
sort
consist
determin
phenotyp
cell
examin
cell
surfac
marker
fa
fasl
trail
intracellular
cytolyt
granul
perforin
granzym
b
fresh
ippexpand
cell
shown
figur
fresh
cell
express
medium
level
fa
trail
perforin
granzym
b
wherea
expand
cell
much
higher
level
perforin
similar
level
fa
trail
granzym
b
compar
fresh
cell
contrast
fresh
expand
cell
express
littl
fasl
figur
effici
kill
human
avian
flua
mdm
cellsto
determin
whether
cell
could
kill
flua
mdm
examin
cytolyt
activ
cocultur
ippexpand
cell
virusinfect
autolog
mdm
cell
show
cytolyt
activ
mockinfect
mdm
display
potent
cytotox
human
flua
avian
flua
mdm
dosedepend
manner
figur
human
flua
mdm
target
cell
effector
kill
virusinfect
mdm
e
ratio
h
cocultur
figur
importantli
similar
result
also
found
avian
flua
avian
flua
mdm
figur
signific
differ
cytotox
cell
flua
virus
figur
inhibit
flua
viru
replic
mdm
cellsto
determin
whether
decreas
viral
load
virusinfect
mdm
cocultur
cell
mdm
target
cultur
alon
ippexpand
cell
effector
e
ratio
day
cocultur
flua
viru
matrix
gene
copi
whole
mdm
cultur
supernat
significantli
reduc
cocultur
virusinfect
mdm
cell
compar
virusinfect
mdm
alon
figur
cytotox
cell
depend
cellcel
contact
requir
virusinfect
mdm
activationto
determin
whether
effici
kill
virusinfect
mdm
cell
depend
cellcel
contact
use
transwel
cultur
system
shown
figur
cell
lost
cytotox
viru
infect
cell
physic
separ
virusinfect
mdm
howev
virusinfect
mdm
put
cell
cytotox
toward
target
bottom
well
also
observ
although
cytolyt
activ
much
lower
direct
cellcel
contact
cocultur
data
suggest
cytotox
cell
depend
cellcel
contact
requir
activ
virusinfect
mdm
diffus
solubl
factor
granul
releas
activ
cell
may
also
involv
sought
confirm
granul
releas
kill
flua
mdm
cell
express
lysosomeassoci
membran
protein
marker
associ
degranul
nk
cell
cytotox
lymphocyt
ctl
significantli
upregul
cell
cocultur
mdm
h
compar
mockinfect
mdm
figur
result
suggest
virusinfect
mdm
trigger
intens
granul
releas
cell
cytotox
cell
depend
activ
mediat
fasfasl
b
pathwaysbecaus
ippexpand
cell
also
express
high
medium
level
fa
trail
determin
whether
fasfasl
trail
pathway
involv
cytotox
use
neutral
antibodi
fasl
found
blockad
fasl
significantli
inhibit
cytolyt
activ
cell
mdm
inhibit
block
fasl
block
contrast
signific
chang
cytolyt
activ
mdm
treatment
trailblock
antibodi
figur
similar
result
also
found
kill
mdm
cell
figur
result
demonstr
fasfasl
pathway
also
involv
kill
mdm
infect
human
avian
flua
virus
cell
confirm
involv
cytolyt
granul
releas
kill
virusinfect
mdm
cell
perforinspecif
inhibitor
cma
granzym
b
inactiv
use
shown
figur
cytolyt
activ
cell
mdm
significantli
abrog
cma
treatment
inhibit
treatment
inhibit
similar
result
also
observ
kill
mdm
cell
figur
result
indic
b
pathway
involv
cytotox
cell
mdm
infect
human
avian
flua
virus
cell
report
play
import
role
defens
pathogen
tumor
broad
antivir
activ
differ
virus
human
vitro
system
cell
shown
potent
cytolyt
activ
virusinfect
cell
suppress
replic
human
immunodefici
viru
hepat
b
viru
herp
simplex
viru
vaccinia
viru
human
cytomegaloviru
sever
acut
respiratori
syndrom
coronaviru
present
studi
focus
cytotox
properti
cell
influenza
viru
infect
cellmedi
cytotox
major
mechan
elimin
virusinfect
cell
thu
elimin
potenti
sourc
new
viru
particular
compon
innat
immun
cell
may
act
earli
respond
viral
control
clearanc
compar
specif
ctl
activ
show
ippexpand
cell
could
kill
human
mdm
h
cocultur
importantli
similar
potent
cytotox
activ
cell
mdm
infect
newli
emerg
avian
flua
viru
precursor
viru
also
found
h
cocultur
furthermor
found
ippexpand
cell
significantli
inhibit
viral
replic
elimin
virusinfect
mdm
best
knowledg
first
studi
demonstr
ippexpand
cell
rapid
potent
antivir
activ
human
avian
flua
virus
consist
find
vitro
studi
found
phosphoantigen
ipp
could
select
activ
expand
human
cell
pbmc
presenc
week
stimul
ipp
cell
expand
fact
phosphoantigen
demonstr
potenti
facilit
largescal
vitro
expans
function
cell
use
adopt
immunotherapi
tumor
infecti
diseas
differ
model
although
lack
murin
counterpart
cell
dramat
hamper
effort
understand
vivo
role
phosphoantigen
cell
select
activ
expans
cell
phosphoantigen
also
confirm
vivo
model
cynomolgu
monkey
sever
combin
immunodefici
mice
engraft
human
peripher
blood
leukocyt
human
pblscid
mice
therefor
phosphoantigen
ipp
could
altern
treat
human
avian
flua
infect
via
target
cell
inde
synthet
phosphoantigen
name
therapeut
aminobisphosphon
pamidron
zoledron
commonli
use
clinic
treat
osteoporosi
lysi
osteoclast
one
concern
regard
immunotherapi
induc
phosphoantigen
whether
cell
traffic
infect
site
lung
flua
viru
infect
cell
express
chemokin
cc
motif
receptor
capabl
diapedesi
cell
abl
migrat
inflammatori
site
recent
studi
macaqu
model
mycobacterium
tuberculosi
infect
demonstr
phosphoantigenspecif
cell
could
accumul
inflammatori
site
lymphoid
nonlymphoid
tissu
includ
lung
suggest
strategi
target
cell
phosphoantigen
may
feasibl
treatment
human
avian
flua
viru
infect
use
nonhuman
primat
model
human
pblscid
mice
evalu
immunotherapi
influenza
viru
infect
vivo
may
acceler
futur
clinic
applic
although
origin
describ
activ
receptor
nk
cell
also
recogn
potent
costimulatori
receptor
cytotox
function
human
cell
recent
demonstr
directli
activ
cell
trigger
releas
cytolyt
granul
recognit
ligand
human
identifi
stressinduc
major
histocompat
complex
class
protein
b
member
protein
famili
ligand
differ
tumor
model
cytotox
report
involv
lysi
tumor
cell
cell
present
studi
show
ippexpand
cell
express
cytotox
cell
mdm
significantli
block
neutral
antibodi
suggest
kill
influenza
cell
cell
requir
activ
recognit
influenza
mdm
express
upregul
major
histocompat
complex
class
protein
b
ligand
could
also
explain
ippexpand
cell
kill
mdm
mockinfect
mdm
present
studi
pathway
also
shown
involv
kill
listeria
macrophag
murin
cell
vivo
found
ippexpand
cell
express
high
level
fa
blockad
fasfasl
pathway
significantli
inhibit
cytotox
cell
mdm
indic
pathway
also
involv
kill
influenza
cell
cell
recent
demonstr
trail
significantli
upregul
avian
flua
virus
human
mdm
compar
avian
flua
mdm
could
induc
cell
apoptosi
trail
pathway
present
studi
howev
show
involv
trail
pathway
kill
mdm
cell
blockad
trail
pathway
reduc
cytotox
cell
either
mdm
use
transwel
system
demonstr
kill
flua
mdm
cell
depend
cellcel
contact
requir
activ
virusinfect
cell
addit
express
increas
cell
cocultur
flua
mdm
cocultur
mockinfect
mdm
support
hypothesi
granul
releas
cell
requir
virusinfect
cell
activ
use
perforin
inhibitor
cma
granzym
b
inactiv
confirm
perforin
granzym
b
facilit
cytolyt
respons
cell
flua
mdm
consist
find
studi
tumor
virusinfect
cell
therefor
human
cell
close
resembl
nk
cell
cytotox
function
use
predominantli
granuleexocytosi
mechan
kill
virusinfect
cell
summari
demonstr
first
time
cell
recogn
effici
kill
mdm
infect
human
avian
flua
virus
thu
contribut
viru
clearanc
cytotox
cell
flua
mdm
depend
activ
mediat
fasfasl
b
pathway
studi
suggest
novel
approach
use
phosphoantigen
activ
cell
flua
viru
emerg
avian
flua
viru
infect
particular
